The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement
Open accessAbstract
BACKGROUND: Graves' orbitopathy (GO) is an autoimmune condition, which is associated with poor clinical outcomes including impaired quality of life and socio-economic status. Current evidence suggests that the incidence of GO in Europe may be declining, however data on the prevalence of this disease are sparse. Several clinical variants of GO exist, including euthyroid GO, recently listed as a rare disease in Europe (ORPHA466682). The objective was to estimate the prevalence of GO and its clinical variants in Europe, based on available literature, and to consider whether they may potentially qualify as rare. Recent published data on the incidence of GO and Graves' hyperthyroidism in Europe were used to estimate the prevalence of GO. The position statement was developed by a series of reviews of drafts and electronic discussions by members of the European Group on Graves' Orbitopathy. The prevalence of GO in Europe is about 10/10,000 persons. The prevalence of other clinical variants is also low: hypothyroid GO 0.02-1.10/10,000; GO associated with dermopathy 0.15/10,000; GO associated with acropachy 0.03/10,000; asymmetrical GO 1.00-5.00/10,000; unilateral GO 0.50-1.50/10,000. CONCLUSION: GO has a prevalence that is clearly above the threshold for rarity in Europe. However, each of its clinical variants have a low prevalence and could potentially qualify for being considered as a rare condition, providing that future research establishes that they have a distinct pathophysiology. EUGOGO considers this area of academic activity a priority.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Incidence of hyperthyroidism in Sweden
Abraham-Nordling, M., Byström, K., Törring, O., Lantz, M., Berg, G., Calissendorff, J., Nyström, H. F., Jansson, S., Jörneskog, G., Karlsson, F. A., et al. (2011) · European Journal of Endocrinology · doi:10.1530/eje-11-0548 · Cited by 251
The thyroid epidemiology, audit, and research study: thyroid dysfunction in the general population
Flynn, R. W. V., MacDonald, T. M., Morris, A. D., Jung, R. T., & Leese, G. P. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032089 · Cited by 196
Morbidity before and after the diagnosis of hyperthyroidism: a nationwide register-based study
Brandt, F., Thvilum, M., Almind, D., Christensen, K., Green, A., Hegedüs, L., & Brix, T. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066711 · Cited by 142 · cited 1×
“2) [1] is an autoimmune condition that targets the orbits [2] and is responsible for significant morbidity [3, 4] including, in rare cases, blindness [5].”
BackgroundSelf-citationBrandt, F., Almind, D., Christensen, K., Green, A., Brix, T. H., & Hegedüs, L. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2268 · Cited by 83
Self-citation
Cited by
Davies, T. F., Andersen, S., Latif, R., Nagayama, Y., Barbesino, G., Brito, M., Eckstein, A. K., Stagnaro-Green, A., & Kahaly, G. J. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0184-y · Cited by 398
Self-citationEpidemiology, Natural History, Risk Factors, and Prevention of Graves’ Orbitopathy
Bartalena, L., Piantanida, E., Gallo, D., Lai, A., & Tanda, M. L. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.615993 · Cited by 369
Self-citationNew insights into the pathogenesis and nonsurgical management of Graves orbitopathy
Taylor, P. N., Zhang, L., Lee, R. W. J., Muller, I., Ezra, D. G., Dayan, C. M., Kahaly, G. J., & Ludgate, M. (2020) · Nature Reviews Endocrinology · doi:10.1038/s41574-019-0305-4 · Cited by 315
Self-citation
Metadata
- Authors
- Perros, P., Hegedüs, L., Bartalena, L., Marcocci, C., Kahaly, G. J., Baldeschi, L., Salvi, M., Lazarus, J. H., Eckstein, A., Pitz, S., Boboridis, K., Anagnostis, P., Ayvaz, G., Boschi, A., Brix, T. H., Currò, N., Konuk, O., Marinò, M., Mitchell, A. L., Stankovic, B., Törüner, F. B., von Arx, G., Zarković, M., & Wiersinga, W. M.
- Venue
- Orphanet Journal of Rare Diseases
- Published
- 2017-04-20
- Volume
- 12
- Issue
- 1
- Pages
- 72-72
- ISSN
- 1750-1172 (ISSN-L)
- OpenAlex
- W2606200598
- Cited by
- 172
- References
- 4
- FWCI
- 8.16
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement. https://app.cochat.ai/papers/10.1186/s13023-017-0625-1
- The paper
- Perros, P., Hegedüs, L., Bartalena, L., Marcocci, C., Kahaly, G. J., Baldeschi, L., Salvi, M., Lazarus, J. H., Eckstein, A., Pitz, S., Boboridis, K., Anagnostis, P., Ayvaz, G., Boschi, A., Brix, T. H., Currò, N., Konuk, O., Marinò, M., Mitchell, A. L., . . . Wiersinga, W. M. (2017). Graves’ orbitopathy as a rare disease in Europe: a European Group on Graves’ Orbitopathy (EUGOGO) position statement. Orphanet Journal of Rare Diseases. https://doi.org/10.1186/s13023-017-0625-1
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.